Market Overview

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PROLOR Biotech, Inc. Shareholders

Share:
NEW YORK--(BUSINESS WIRE)--

Kirby McInerney LLP is investigating potential claims against the Board of Directors of PROLOR Biotech, Inc. (“PROLOR” or the “Company”) (NYSE: PBTH) related to the proposed acquisition of the Company by OPKO Health, Inc. (“OPKO”) (NYSE: OPK). Under the terms of the proposal, PROLOR shareholders will receive 0.9951 shares of OPKO common stock for each share of PROLOR common stock. In total, the transaction is valued at approximately $480 million, or $7.00 per share of PROLOR common stock.

The investigation concerns whether the PROLOR Board of Directors violated its fiduciary duties by agreeing to this transaction and whether the proposed $7.00 per share consideration adequately values PROLOR common shares.

If you are a PROLOR shareholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or by telephone at (212) 699-1145 or (888) 529-4787.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145 or 888-529-4787
bwalker@kmllp.com

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com